Gene Expression Cancer Classification Using Recursive Clustering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer diagnosis methods, particularly for childhood cancers, are often delayed, incorrect, or missed due to differences between adult and childhood tumors, and lack comprehensive molecular assays for accurate classification.

Innovation Solution

A computer-implemented method and system using recursive clustering and machine learning models, such as convolutional neural networks and Gradient Boosting ensembles, to classify cancer types from gene expression data, incorporating features like variance removal, non-linear dimensionality reduction, and hierarchical clustering to identify tumor subtypes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If genome sequencing is used to detect cancer fusions, then diagnostic markers can be identified, but the method has limited diagnostic utility beyond these markers and cannot comprehensively diagnose all pediatric cancers

Engineering Contradiction:
Improvedetection of pathognomonic fusionsVSAvoiddiagnostic utility across all cancer types
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent develops a universal machine learning classifier that can diagnose multiple types of pediatric cancers simultaneously using gene expression data. The system is trained on diverse cancer types including leukemia, lymphoma, neuroblastoma, and sarcoma, enabling it to comprehensively classify tumors across different origins and characteristics, thereby achieving multi-functionality in cancer diagnosis

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of manufacture

If adult cancer classification methods are applied to childhood cancers, then existing diagnostic frameworks can be used, but accuracy decreases due to fundamental differences between adult and childhood tumor biology

Engineering Contradiction:
Improveuse of existing diagnostic frameworksVSAvoiddiagnostic accuracy for childhood cancers
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent creates specialized classification models tailored to childhood cancer characteristics. The system incorporates features specific to pediatric tumors such as embryonal origin markers, childhood-specific fusion genes, and age-related expression patterns. This local customization ensures the diagnostic tool accurately captures the unique biology of childhood cancers rather than forcing them into adult cancer classification frameworks

Inventive Principle:
Principle #3Local quality

3Measurement precision

If comprehensive molecular assays are developed for all pediatric cancers, then diagnostic accuracy improves, but the complexity and cost of the system increases

Engineering Contradiction:
Improvecomprehensive cancer classification accuracyVSAvoidmolecular assay system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transforms the cancer diagnosis approach by changing from detecting specific molecular markers to analyzing overall gene expression patterns. The machine learning classifier processes high-dimensional gene expression data to identify diagnostic patterns, thereby achieving comprehensive cancer classification through a unified computational framework rather than multiple separate molecular assays

Inventive Principle:
Principle #35Parameter changes

4Ease of operation

If traditional cancer diagnosis methods are used, then existing protocols can be followed, but diagnosis is frequently delayed, incorrect, or missed entirely

Engineering Contradiction:
Improveuse of existing diagnostic protocolsVSAvoiddiagnosis time for childhood cancers
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent replaces manual pathological examination and traditional diagnostic workflows with an automated machine learning classification system. The computational model rapidly analyzes gene expression data and provides diagnostic classifications, eliminating the time delays and subjectivity inherent in traditional methods while maintaining ease of use through standardized input requirements

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20250384957A1System and method for classifying cancer and classifying benign and malignant neoplasm
Publication Date: 2025.12.18 HOSPITAL FOR SICK CHILDREN
  • US20250384957A1 patent drawing
  • US20250384957A1 patent drawing
  • US20250384957A1 patent drawing

AI summary

The present invention relates to systems and methods for classification of cancer from gene expression input data. The method including: receiving a training dataset including nucleic acid data points from one or more samples; identifying classes in the training dataset including performing recursive clustering by, at each successive iteration, performing a search to identify clusters based on similarity, wherein each class of the classes is associated with a tumor; training a machine learning model to associate the nucleic acid data points of the training dataset with the identified classes; receiving the gene expression input data for classification; classifying, using the trained machine learning model, the gene expression input data as one or more of the identified classes; and outputting the classification of the gene expression input data.